Vigilare Wealth Management - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Vigilare Wealth Management ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$262,000
-48.7%
5,690
-26.2%
0.22%
-28.8%
Q4 2021$511,000
-1.4%
7,705
-7.1%
0.30%
-5.6%
Q3 2021$518,000
+25.7%
8,295
+66.9%
0.32%
+28.0%
Q2 2021$412,000
+95.3%
4,970
+56.3%
0.25%
+66.7%
Q1 2021$211,0003,1800.15%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders